HCA Healthcare financials
$431.63−0.22%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B | $17.49B | $17.34B | $17.30B | $16.21B |
| Gross profit | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B | $17.49B | $17.34B | $17.30B | $16.21B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $3.07B | $2.86B | $3.21B | $2.96B | $2.97B | $2.85B | $2.86B | $2.41B | $2.73B | $2.56B | $2.80B | $2.09B |
| Net income | $1.70B | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B | $1.27B | $1.46B | $1.59B | $1.61B | $1.08B |
| Net margin | 8.4% | 8.5% | 9.6% | 8.6% | 8.9% | 8.8% | 7.9% | 7.3% | 8.4% | 9.2% | 9.3% | 6.7% |
| Diluted EPS | $7.62 | $7.15 | $8.15 | $6.96 | $6.83 | $6.45 | $5.63 | $4.88 | $5.53 | $5.93 | $5.93 | $3.91 |
| EBITDA | $4.01B | $3.79B | $4.13B | $3.85B | $3.83B | $3.71B | $3.72B | $3.25B | $3.55B | $3.35B | $2.80B | $2.86B |
| Operating cash flow | $2.33B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B | $3.52B | $1.97B | $2.47B | $2.67B | $2.48B |
| Free cash flow | $1.10B | $895.0M | $870.0M | $3.13B | $3.03B | $660.0M | $1.27B | $2.32B | $690.0M | $1.35B | $1.51B | $1.33B |
| Diluted shares | 222.8M | 226.7M | 230.4M | 236.2M | 241.9M | 249.4M | 255.2M | 259.9M | 264.1M | 268.0M | 271.1M | 275.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.01B | $940.0M | $1.04B | $997.0M | $939.0M | $1.06B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $49.72B | $48.02B | $46.49B | $44.51B | $44.48B | $44.58B |
| Total assets | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B |
| Total liabilities | $66.46B | $64.43B | $63.49B | $61.91B | $60.77B | $60.24B |
| Shareholders' equity | -$3.21B | -$2.98B | -$2.77B | -$2.16B | -$1.24B | -$438.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology